What is Halodoc?
Founded in 2016, Halodoc serves as a critical digital infrastructure for healthcare access in Indonesia. The platform functions as a centralized hub, seamlessly connecting millions of users with licensed medical professionals, pharmacies, and diagnostic laboratories. By offering 24/7 teleconsultation services, medicine delivery, and home-based lab testing, Halodoc addresses the logistical challenges of healthcare delivery in a geographically dispersed market. Its business model leverages mobile technology to provide a frictionless patient experience, effectively digitizing the traditional clinical journey and enhancing overall health outcomes for its user base.
How much funding has Halodoc raised?
Halodoc has raised a total of $258M across 4 funding rounds:
Series A
$13M
Series B
$65M
Series C
$80M
Series D
$100M
Series A (2016): $13M with participation from Blibli, NSI Ventures, GoJek, and Clermont Group
Series B (2018): $65M led by UOB Venture Management
Series C (2021): $80M supported by Asta International and Temasek
Series D (2023): $100M featuring Pt Astra Digital Internasional
Key Investors in Halodoc
Pt Astra Digital Internasional
Astra Digital serves as the digital and strategy arm of Astra International, focusing on delivering innovative value propositions and driving digital transformation across the group's diverse portfolio.
Temasek
Temasek is a global investment company headquartered in Singapore that operates as a generational investor, prioritizing long-term value creation and sustainable growth.
UOB Venture Management
UOB Venture Management is a specialized venture capital firm that provides strategic investment solutions to high-growth technology and digital companies seeking to scale their operations.
What's next for Halodoc?
Looking ahead, Halodoc is positioned to leverage its recent capital influx to deepen its technological moat and expand its service offerings. The strategic focus will likely center on enhancing AI-driven diagnostic tools and strengthening its logistics network to ensure faster medicine delivery. As the company matures, it is expected to explore further integration with national health insurance systems and private healthcare providers, solidifying its role as an indispensable component of the regional digital health infrastructure. The ongoing support from high-profile institutional backers suggests a long-term commitment to scaling operations and maintaining market leadership in the evolving health-tech sector.
See full Halodoc company page